Mortality among problem drug users in Rome: an 18-year follow-up study, 1980-97

Addiction ◽  
2001 ◽  
Vol 96 (10) ◽  
pp. 1455-1463 ◽  
Author(s):  
A. M. Bargagli ◽  
A. Sperati ◽  
M. Davoli ◽  
F. Forastiere ◽  
C. A. Perucci
2009 ◽  
Vol 15 (4) ◽  
pp. 179-187 ◽  
Author(s):  
Marcel C.A. Buster ◽  
Ewald Witteveen ◽  
Maria Prins ◽  
Erik J.C. van Ameijden ◽  
Gerard Schippers ◽  
...  

2011 ◽  
Vol 50 (2) ◽  
pp. 49-65 ◽  
Author(s):  
Heike Zurhold ◽  
Jacek Moskalewicz ◽  
Cristina Sanclemente ◽  
Gabriele Schmied ◽  
David Shewan ◽  
...  

2009 ◽  
Vol 18 (1) ◽  
pp. 59-70 ◽  
Author(s):  
Siavash Jafari ◽  
Afarin Rahimi-Movaghar ◽  
Kevin J.P. Craib ◽  
Souzan Baharlou ◽  
Richard Mathias

1978 ◽  
Vol 8 (3) ◽  
pp. 173-179 ◽  
Author(s):  
Robert Guinn

This follow-up study was undertaken to assess consistencies or changes in attitudes and behavior of self-reported Mexican American drug users from 1973 (N=254) to 1977 (N=150). Analysis of the data indicated significant changes in the users' socioeconomic status, home environment, school related variables, and attitudes toward drug use. Drug users were consistent in their views on how to deal with a drug problem if one is perceived and their confidence in selected social institutions.


1987 ◽  
Vol 22 (2) ◽  
pp. 239-239
Author(s):  
C Marti-Gaudes ◽  
J Llorens-Terol ◽  
A Mur

2005 ◽  
Vol 134 (4) ◽  
pp. 814-819 ◽  
Author(s):  
K. STARK ◽  
U. HERRMANN ◽  
S. EHRHARDT ◽  
U. BIENZLE

In two prisons in Berlin, Germany, provision of sterile injection equipment for injecting drug users (IDUs) started in 1998. To assess the programme's impact, the frequency of injecting drug use and syringe sharing, and the incidence of HIV, HBV, and HCV infection were determined in a follow-up study. Of all IDUs (n=174), 75% continued to inject. After the project start the level of syringe sharing declined from 71% during a 4-month period of previous imprisonment to 11% during the first 4 months of follow-up, and to virtually zero thereafter. Baseline seroprevalences for HIV, HBV, and HCV were 18, 53, and 82%. HIV and HCV seroprevalence at baseline was significantly associated with drug injection in prison prior to the project start. No HIV and HBV seroconversions, but four HCV seroconversions occurred. The provision of syringes for IDUs in appropriate prison settings may contribute to a substantial reduction of syringe sharing. However, the prevention of HCV infection requires additional strategies.


Sign in / Sign up

Export Citation Format

Share Document